News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
151 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37188)
2018 (39119)
2019 (51334)
2020 (57663)
2021 (58720)
2022 (53928)
2023 (42564)
2024 (37441)
2025 (33091)
2026 (18653)
Month
January (2433)
February (2866)
March (3029)
April (3115)
May (3356)
June (2725)
July (1129)
Day
1 (121)
2 (97)
3 (8)
5 (6)
6 (80)
7 (151)
8 (89)
9 (81)
10 (30)
13 (140)
14 (106)
15 (102)
16 (118)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
Day
1
2
3
5
6
7
8
9
10
13
14
15
16
Press Releases
Catalent and Nanoscope Therapeutics Expand Partnership to Support Late-Phase Development and Commercial Supply of Lead Optogenetic Gene therapy, MCO-010
July 7, 2026
·
3 min read
Job Trends
Novartis slashes New Jersey workforce again, cutting 322 employees
With the latest layoffs, Novartis expects to let go of around 800 employees by the end of 2028. More than half of the cuts have been at the company’s East Hanover, New Jersey, location.
July 7, 2026
·
1 min read
·
Angela Gabriel
Psychedelics
Compass’ psilocybin depression drug works for the long haul
New data from a Phase 3 trial will further support a rolling submission for Compass Pathways’ psilocybin treatment COMP360. Patients who saw a clinically meaningful benefit on depression severity maintained response through week 26.
July 7, 2026
·
2 min read
·
Annalee Armstrong
Press Releases
PDV MedTech and Corscience Announce Strategic Partnership to Advance MedTech Development and Manufacturing Across the US and Europe
July 7, 2026
·
4 min read
Press Releases
Nyra Medical Announces First Patient Enrollment in ENHANCE Early Feasibility Study, Advancing Next Generation Mitral Valve Repair Platform
July 7, 2026
·
5 min read
Press Releases
Biomerics Appoints Wil Boren to Its Advisory Board
July 7, 2026
·
3 min read
Press Releases
The University of Colorado Anschutz, along with UCHealth and Children’s Hospital Colorado, Form Strategic Alliance with Bayer to Advance Drug Development and Clinical Trials
July 7, 2026
·
8 min read
Press Releases
New England Biolabs® launches the NEBNext® Companion Module for Oxford Nanopore Technologies® Direct RNA Sequencing
July 7, 2026
·
2 min read
Press Releases
Insilico Initiates Phase III Clinical Trial for Rentosertib, Its AI-Empowered TNIK Inhibitor for Idiopathic Pulmonary Fibrosis
July 7, 2026
·
15 min read
Press Releases
Pangea Pharmaceuticals Advances Its Next Phase of Growth With an Expanding Commercial Portfolio
July 7, 2026
·
5 min read
Previous
13 of 16
Next
